Sanofi
SNY
#121
Rank
$116.48 B
Marketcap
$46.30
Share price
2.00%
Change (1 day)
-16.91%
Change (1 year)

Sanofi is a French pharmaceutical company created in 2004 by the merger of Sanofi-Synthรฉlabo and Aventis. With sales of EUR 36.1 billion in 2019 and more than 100,000 employees worldwide, Sanofi is one of the largest pharmaceutical companies in the world in terms of sales.

Operating Margin for Sanofi (SNY)

Operating Margin as of April 2024 (TTM): 18.21%

According to Sanofi's latest financial reports and stock price the company's current Operating Margin is 18.21%. At the end of 2022 the company had an Operating Margin of 18.22%.

Operating Margin history for Sanofi from 2002 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
202218.22%-8.49%
202119.91%-46.11%
202036.94%392.59%
20197.50%-39.26%
201812.35%-19.17%
201715.27%-6.63%
201616.36%8.77%
201515.04%-10.49%
201416.80%21.57%
201313.82%-15.44%
201216.34%7.73%
201115.17%-13.19%
201017.48%-11.4%
200919.73%-40.11%
200832.94%66.67%
200719.76%22.75%
200616.10%73.68%
20059.27%-175.64%
2004-12.25%-131.47%
200338.94%15.79%
200233.63%1.96%
200132.98%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
22.88% 25.65%๐Ÿ‡บ๐Ÿ‡ธ USA
17.27%-5.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
34.61% 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
39.02% 114.28%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
15.60%-14.33%๐Ÿ‡บ๐Ÿ‡ธ USA
24.66% 35.42%๐Ÿ‡บ๐Ÿ‡ธ USA
27.73% 52.28%๐Ÿ‡บ๐Ÿ‡ธ USA
19.24% 5.66%๐Ÿ‡บ๐Ÿ‡ธ USA
22.54% 23.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
-20.53%-212.74%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.